Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bocchia

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
European Journal of Haematology. Supplementum|January 1, 1990
Relationship between immunological phenotype and hematological response to alpha-IFN treatment in 35 patients with hairy cell leukemiaF Lauria, P L Zinzani, D Raspadori, et al.
Haematologica|January 1, 1990
Hairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 casesP L Zinzani, F Lauria, M Buzzi, et al.
Leukemia & Lymphoma|March 18, 2000
Fludarabine containing-regimens may adversely affect peripheral blood stem cell collection in low-grade non Hodgkin lymphoma patientsD Laszlo, P Galieni, D Raspadori, et al.
Journal of Biological Regulators and Homeostatic Agents|September 23, 2016
A solitary uterine relapse in T-cell Acute Lymphoblastic Leukaemia: CT features and pathologic correlationM A Mazzei, G Bettini, C Pozzessere, et al.
European Journal of Haematology|July 1, 1992
Recombinant interleukin-2 (rIL-2) in acquired immune deficiency syndrome (AIDS): preliminary report in patients with lymphoma associated with HIV infectionP Mazza, M Bocchia, F Tumietto, et al.
British Journal of Haematology|March 1, 1994
Anaplastic large cell lymphoma (CD30 +/Ki-1+): results of a prospective clinico-pathological study of 69 casesS Pileri, M Bocchia, C D Baroni, et al.
Leukemia & Lymphoma|September 1, 1992
Massive mediastinal involvement in stage I-II Hodgkin's disease: response to combined modality treatmentP L Zinzani, P Mazza, F Gherlinzoni, et al.
Tumori|December 31, 1990
CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary reportP L Zinzani, P Mazza, F Gherlinzoni, et al.
Leukemia|January 1, 1991
MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomasS Tura, F Mandelli, P Mazza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphomaP L Zinzani, F Lauria, D Rondelli, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
European Journal of Haematology. Supplementum|January 1, 1990
Relationship between immunological phenotype and hematological response to alpha-IFN treatment in 35 patients with hairy cell leukemiaF Lauria, P L Zinzani, D Raspadori, et al.
Haematologica|January 1, 1990
Hairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 casesP L Zinzani, F Lauria, M Buzzi, et al.
Leukemia & Lymphoma|March 18, 2000
Fludarabine containing-regimens may adversely affect peripheral blood stem cell collection in low-grade non Hodgkin lymphoma patientsD Laszlo, P Galieni, D Raspadori, et al.
Journal of Biological Regulators and Homeostatic Agents|September 23, 2016
A solitary uterine relapse in T-cell Acute Lymphoblastic Leukaemia: CT features and pathologic correlationM A Mazzei, G Bettini, C Pozzessere, et al.
European Journal of Haematology|July 1, 1992
Recombinant interleukin-2 (rIL-2) in acquired immune deficiency syndrome (AIDS): preliminary report in patients with lymphoma associated with HIV infectionP Mazza, M Bocchia, F Tumietto, et al.
British Journal of Haematology|March 1, 1994
Anaplastic large cell lymphoma (CD30 +/Ki-1+): results of a prospective clinico-pathological study of 69 casesS Pileri, M Bocchia, C D Baroni, et al.
Leukemia & Lymphoma|September 1, 1992
Massive mediastinal involvement in stage I-II Hodgkin's disease: response to combined modality treatmentP L Zinzani, P Mazza, F Gherlinzoni, et al.
Tumori|December 31, 1990
CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary reportP L Zinzani, P Mazza, F Gherlinzoni, et al.
Leukemia|January 1, 1991
MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomasS Tura, F Mandelli, P Mazza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphomaP L Zinzani, F Lauria, D Rondelli, et al.
Pageof 7